Evidence map›Paper›PMID 33050927›Full record

ArticleGenome biology2020

iMOKA: k-mer based software to analyze large collections of sequencing data.

Claudio Lorenzi, Sylvain Barriere, Jean-Philippe Villemin, Laureline Dejardin Bretones, Alban Mancheron, William Ritchie

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Genome biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. A survey of k-mer methods and applications in bioinformatics.Computational and structural biotechnology journal · 2024
    Review
  6. SHARK enables sensitive detection of evolutionary homologs and functional analogs in unalignable and disordered sequences.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudio LorenziIGH, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France.
Sylvain BarriereIGH, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France.
Jean-Philippe VilleminIGH, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France.
Laureline Dejardin BretonesIGH, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France.
Alban MancheronLIRMM, Université de Montpellier, CNRS, Montpellier, France.
William RitchieIGH, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France. william.ritchie@igh.cnrs.fr.ORCID 0000-0001-8162-1439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

iMOKA (interactive multi-objective k-mer analysis) is a software that enables comprehensive analysis of sequencing data from large cohorts to generate robust classification models or explore specific genetic elements associated with disease etiology. iMOKA uses a fast and accurate feature reduction step that combines a Naïve Bayes classifier augmented by an adaptive entropy filter and a graph-based filter to rapidly reduce the search space. By using a flexible file format and distributed indexing, iMOKA can easily integrate data from multiple experiments and also reduces disk space requirements and identifies changes in transcript levels and single nucleotide variants. iMOKA is available at https://github.com/RitchieLabIGH/iMOKA and Zenodo https://doi.org/10.5281/zenodo.4008947 .

Indexed as

Sequence Analysis, DNASoftwareAlgorithmsDrug Resistance, NeoplasmFemaleHumansOvarian NeoplasmsPharmacogenomic VariantsBioinformatics softwareData reductionk-merMachine learningNGS analysisPersonalized medicine

Identifiers

PMID33050927
PMCPMC7552494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.